via Cardiff University
New research from Cardiff University, in collaboration with Astra Zeneca, used artificial intelligence to create microscopic particles which can effectively transport medicines to precisely target and treat diseased cells.
The team say their work has potential future applications in treating genetic diseases and cancer as well as infectious disease.
Professor Arwyn T Jones, Cardiff University’s School of Pharmacy and Pharmaceutical sciences, said: “We are continually looking for new and improved ways of delivering drugs around the human body. Nanoparticles are tiny particles that can act as microscopic shuttles to transport and deliver therapeutic molecules – medications —around the body to reach the specific site that needs therapeutic intervention.
“By taking these drug molecules to the right location in the body, the nanoparticles can help to treat several different diseases.”
This collaborative study used AI to design a bespoke nanoparticle to deliver a drug molecule, called mRNA, to cancer cells. This AI-designed nanoparticle was then proven to be more effective as a delivery shuttle compared with other prototypes.
“This research showed that machine learning and artificial intelligence can form an integral part of the design process for constructing more effective nano therapeutics.
“Whilst the nanoparticle generated through this study was within a narrow field of biomedical research, the new technique — based on computational learning and subsequent design of a new nanoparticle shuttle — was proven to be effective. This means this new technique could be used to analyze and design thousands of different types of nanoparticles and deliver hundreds of different types of therapeutic molecules to target a very wide range of diseases,” added Professor Jones.
Nanoparticles are currently used in medical treatment, however scientists manufacture and test often hundreds of nanoparticle designs before identifying the best one – a process that can take years. This new method shows how AI can rapidly accelerate the development of nanoparticles.
“This approach gains information on how cells and proteins in cells regulate the performance of nanoparticles as drug delivery agents. It clearly demonstrates that machine learning can make a significant contribution to efficiently design more effective nanotherapeutics to better target and treat disease,” added Professor Jones.
Original Article: AI-generated nanoparticles prove capable of delivering modern medicines to diseased cells
More from: Cardiff University
The Latest Updates from Bing News
Go deeper with Bing News on:
Nanoparticle drug delivery
- Nanoparticle researchers develop microfluidic platform for better delivery of gene therapy for lung disease
Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis.
- Nanotechnology in Therapeutics
Nanomedicine. 2012;7(8):1253-1271. Although passive targeting approaches form the basis of clinical therapy, they suffer from several limitations. Ubiquitously targeting cells within a tumor is ...
- Nanotechnology in Therapeutics
Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...
- Phosphorex and NOF CORPORATION Collaborate to Supply Lipid Nanoparticle Formulations using NOF's Proprietary Ionizable Lipid, COATSOME® SS Series
Phosphorex, an Ampersand Capital Partners company and drug delivery-focused contract development and manufacturing organization ("CDMO"), announced today a collaboration with NOF CORPORATION to supply ...
- Penn bioengineering professor develops lipid nanoparticles to deliver mRNA inside human cells
Mitchell leads a biomaterials and drug delivery lab at Penn Engineering that works on engineering new biomaterials, such as lipid nanoparticles.
Go deeper with Bing News on:
AI-designed nanoparticle
- Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
A research team has developed a fentanyl sensor that is six orders of magnitude more sensitive than any electrochemical sensor for the drug reported in the past five years. The portable sensor can ...
- The Top Generative AI Tools For Art And Design
This article highlights the top tools driving this revolution including Dall-E, Midjourney, and Adobe Firefly each with unique features that support artists and designers ...
- What type of tech does biotech use?
Genomic sequencing technologies Genomic sequencing has revolutionized the biotech industry by allowing scientists to analyze and manipulate genetic material with unprecedented precision. ...
- NANITE AWARDED $1.8M TO DEVELOP AI-DRIVEN GENE THERAPY FOR HIV
Nanite, Inc. today announced a $1.8M grant from the Bill & Melinda Gates Foundation to design and optimize polymeric delivery vehicles to deliver DNA-encoded therapeutics.
- Innovative nanoparticle breaks blood-brain barrier to target breast cancer and brain metastases
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed a nanoparticle that can penetrate the blood-brain barrier.